Home › Research › Drug development
Step-by-step monitoring of a magnetic and SERS-active immunosensor assembly for purification and detection of tau protein
Maurer V, Frank C, Porsiel JC, Zellmer S, Garnweitner G, Stosch R.. Journal of biophotonics, 2019-12-03
Topic: Brain proteins, microglia and lab models
Plain-language summary
We report a bottom-up synthesis of iron oxide and gold nanoparticles, which are functionalized and combined to form a nanohybrid serving as an immune sensor, which selectively binds to tau protein, a biomarker for diagnosis of Alzheimer's disease. Detection of the target analyte is achieved by surface-enhanced Raman scattering originating from the diagnostic part of the nanohybrid that was prepared from Au nanoparticles functionalized with 5,5'-dithiobis-(2-nitrobenzoic acid) as a Raman reporter and monoclonal anti-tau antibody. The magnetic part consists of Fe x O y nanoparticles functionalized with polyclonal anti-tau antibody and is capable to separate tau protein from a complex matrix such as cerebrospinal fluid. We further identified and validated a set of analytical tools that allow monitoring the success of both nanoparticle preparation and each functionalization step performed during the assembly of the two binding sites by an immune reaction. By applying UV/Vis spectroscopy, dynamic light scattering, zeta potential measurements, X-ray diffraction, small-angle X-ray scattering, and transmission electron microscopy, we demonstrate a proof-of-concept for a controlled and step-by-step traceable synthesis of a tau protein-specific immune sensor.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Maurer, V., Frank, C., Porsiel, J. C., Zellmer, S., Garnweitner, G., & Stosch, R. (2020). Step-by-step monitoring of a magnetic and SERS-active immunosensor assembly for purification and detection of tau protein. Journal of biophotonics. https://doi.org/10.1002/jbio.201960090
Vancouver
Maurer V, Frank C, Porsiel JC, Zellmer S, Garnweitner G, Stosch R. Step-by-step monitoring of a magnetic and SERS-active immunosensor assembly for purification and detection of tau protein. Journal of biophotonics. 2020. doi:10.1002/jbio.201960090. PMID: 31721451.
BibTeX
@article{maurer2020-31721451,
author = {Maurer, V. and Frank, C. and Porsiel, J. C. and Zellmer, S. and Garnweitner, G. and Stosch, R.},
title = {{Step-by-step monitoring of a magnetic and SERS-active immunosensor assembly for purification and detection of tau protein}},
journal = {Journal of biophotonics},
year = {2020},
doi = {10.1002/jbio.201960090},
pmid = {31721451},
url = {https://doi.org/10.1002/jbio.201960090}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We report a bottom-up synthesis of iron oxide and gold nanoparticles, which are functionalized and combined to form a nanohybrid serving as an immune sensor, which selectively binds to tau protein, a biomarker for diagnosis of Alzheimer's disease.
- Detection of the target analyte is achieved by surface-enhanced Raman scattering originating from the diagnostic part of the nanohybrid that was prepared from Au nanoparticles functionalized with 5,5'-dithiobis-(2-nitrobenzoic acid) as a Raman reporter and monoclonal anti-tau antibody.
- The magnetic part consists of Fe x O y nanoparticles functionalized with polyclonal anti-tau antibody and is capable to separate tau protein from a complex matrix such as cerebrospinal fluid.
- We further identified and validated a set of analytical tools that allow monitoring the success of both nanoparticle preparation and each functionalization step performed during the assembly of the two binding sites by an immune reaction.
- By applying UV/Vis spectroscopy, dynamic light scattering, zeta potential measurements, X-ray diffraction, small-angle X-ray scattering, and transmission electron microscopy, we demonstrate a proof-of-concept for a controlled and step-by-step traceable synthesis of a tau protein-specific immune sensor.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 24 of the 58 points we could judge it on, which is 41 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of biophotonics) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31721451) |
| Free to read | 2 / 2 | Free to read |
| Points | 24 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 24 of the 58 points we could judge it on is 41 out of 100. |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.